Get started
NOVONESIS A SNOVONESIS A SNOVONESIS A S

NOVONESIS A S

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪29.52 B‬ USD
Dividend yield (indicated)
1.68%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪315.68 M‬ USD
Revenue (FY)
‪3.96 B‬ USD
Shares float
‪343.93 M‬
Beta (1Y)
0.20

Employees


Employees (FY)
‪10.58 K‬
Change (1Y)
‪+3.83 K‬ +56.63%
Revenue / Employee (1Y)
‪373.97 K‬ USD
Net income / Employee (1Y)
‪29.83 K‬ USD

About Novonesis A/S Class B


Sector
Process Industries
Industry
Chemicals: Specialty
CEO
Ester Baiget
Website
novonesis.com
Headquarters
Lyngby
IPO date
May 27, 1905
Identifiers
2
ISIN DK0060336014
Novonesis (Novozymes A/S) engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.

Check out other big names from the same industry as NVZMF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


VXUS
Vanguard Total International Stock ETF
Weight
0.06%
Market value
‪325.08 M‬
USD
VEA
Vanguard FTSE Developed Markets ETF
Weight
0.08%
Market value
‪210.07 M‬
USD
IEFA
iShares Core MSCI EAFE ETF
Weight
0.09%
Market value
‪152.96 M‬
USD
EFA
iShares MSCI EAFE ETF
Weight
0.10%
Market value
‪77.62 M‬
USD
XACTC25
XACT OMXC25 ESG (UCITS ETF)
Weight
6.61%
Market value
‪58.71 M‬
USD
VGK
Vanguard FTSEEuropean ETF
Weight
0.15%
Market value
‪55.00 M‬
USD
VEU
Vanguard FTSE All World Ex US ETF
Weight
0.06%
Market value
‪48.56 M‬
USD
SCHF
Schwab International Equity ETF
Weight
0.07%
Market value
‪45.69 M‬
USD
DFIV
Dimensional International Value ETF
Weight
0.23%
Market value
‪43.35 M‬
USD
JIRE
JPMorgan International Research Enhanced Equity ETF
Weight
0.35%
Market value
‪36.46 M‬
USD
ADEF
Apostle Dundas Global Equity Fund Units Class D
Weight
1.89%
Market value
‪34.44 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of NVZMF is 64.13 USD — it has increased by 7.94% in the past 24 hours. Watch NOVONESIS A S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange NOVONESIS A S stocks are traded under the ticker NVZMF.
NVZMF stock has risen by 6.02% compared to the previous week, the month change is a −2.33% fall, over the last year NOVONESIS A S has showed a 14.11% increase.
We've gathered analysts' opinions on NOVONESIS A S future price: according to them, NVZMF price has a max estimate of 89.18 USD and a min estimate of 59.69 USD. Watch NVZMF chart and read a more detailed NOVONESIS A S stock forecast: see what analysts think of NOVONESIS A S and suggest that you do with its stocks.
NVZMF reached its all-time high on Jun 7, 2011 with the price of 174.65 USD, and its all-time low was 23.38 USD and was reached on Aug 2, 2012. View more price dynamics on NVZMF chart.
See other stocks reaching their highest and lowest prices.
NVZMF stock is 7.35% volatile and has beta coefficient of 0.20. Track NOVONESIS A S stock price on the chart and check out the list of the most volatile stocks — is NOVONESIS A S there?
Today NOVONESIS A S has the market capitalization of ‪29.52 B‬, it has increased by 1.56% over the last week.
Yes, you can track NOVONESIS A S financials in yearly and quarterly reports right on TradingView.
NOVONESIS A S is going to release the next earnings report on Feb 25, 2026. Keep track of upcoming events with our Earnings Calendar.
NVZMF earnings for the last quarter are 0.48 USD per share, whereas the estimation was 0.64 USD resulting in a −24.85% surprise. The estimated earnings for the next quarter are 0.93 USD per share. See more details about NOVONESIS A S earnings.
NOVONESIS A S revenue for the last quarter amounts to ‪1.25 B‬ USD, despite the estimated figure of ‪1.25 B‬ USD. In the next quarter, revenue is expected to reach ‪1.20 B‬ USD.
NVZMF net income for the last quarter is ‪161.50 M‬ USD, while the quarter before that showed ‪160.80 M‬ USD of net income which accounts for 0.43% change. Track more NOVONESIS A S financial stats to get the full picture.
NOVONESIS A S dividend yield was 1.52% in 2024, and payout ratio reached 124.39%. The year before the numbers were 1.67% and 56.80% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has ‪10.58 K‬ employees. See our rating of the largest employees — is NOVONESIS A S on this list?
Like other stocks, NVZMF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVONESIS A S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVONESIS A S technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVONESIS A S stock shows the buy signal. See more of NOVONESIS A S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.